Article Versions Notes

Wu T-C, Liao C-Y, Lin Y-Y, Chuang S-M, Liu S-Y, Wang C-H, Su S-E, Wu S-W, Wang L-I, Chen W-T, et al. LT1-3, a Slit2-Derived Peptide, Exhibits Anti-Tumor Activity and Improves Cisplatin Therapy. Cells. 2025; 14(21):1654. https://doi.org/10.3390/cells14211654

Wu, Ting-Chien, Chen-Yi Liao, Yu-Ying Lin, Shu-Ming Chuang, Szu-Yu Liu, Chi-Hsiang Wang, Shang-Er Su, Siang-Wei Wu, Ling-I Wang, Wei-Ting Chen, and et al. 2025. "LT1-3, a Slit2-Derived Peptide, Exhibits Anti-Tumor Activity and Improves Cisplatin Therapy" Cells 14, no. 21: 1654. https://doi.org/10.3390/cells14211654

Wu, T.-C., Liao, C.-Y., Lin, Y.-Y., Chuang, S.-M., Liu, S.-Y., Wang, C.-H., Su, S.-E., Wu, S.-W., Wang, L.-I., Chen, W.-T., Cheng, S.-W., Huang, Y.-T., Zheng, Y.-B., Chuang, C.-Y., Lung, F.-D., & Chang, J. T. (2025). LT1-3, a Slit2-Derived Peptide, Exhibits Anti-Tumor Activity and Improves Cisplatin Therapy. Cells, 14(21), 1654. https://doi.org/10.3390/cells14211654